Cyclo Therapeutics, Inc. Profile Avatar - Palmy Investing

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment …

Drug Manufacturers - Specialty & Generic
US, Gainesville [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Cyclo Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Cyclo Therapeutics, Inc. has no acquisition track records yet.

End of CYTH's Analysis
CIK: 922247 CUSIP: - ISIN: US23254X2018 LEI: - UEI: -
Secondary Listings
CYTH has no secondary listings inside our databases.